Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia

Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
Condition:   Oropharyngeal Dysphagia
Interventions:   Biological: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR);   Other: Placebo
Sponsors:   University of California, Davis;   California Institute for Regenerative Medicine (CIRM);   Cook MyoSite
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments